NeuroPace, Inc. (NPCE)
NASDAQ·Healthcare·Medical - Devices
$16.89
-2.14%
Mkt Cap $565.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $24.75M | $26.59M | +7.44% | -$0.14 | -$0.08 | +42.86% | — | — |
| Q4 2025 Nov 4, 2025 | $25.03M | $27.35M | +9.27% | -$0.20 | -$0.11 | +45.00% | — | — |
| Q3 2025 Aug 12, 2025 | $24.43M | $23.52M | -3.74% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q2 2025 May 13, 2025 | $22.71M | $22.52M | -0.82% | -$0.26 | -$0.21 | +19.23% | — | — |
| Q1 2025 Mar 4, 2025 | $21.56M | $21.47M | -0.44% | -$0.25 | -$0.18 | +28.00% | — | — |
| Q4 2024 Nov 12, 2024 | $20.91M | $21.06M | +0.72% | -$0.26 | -$0.19 | +26.92% | — | — |
| Q3 2024 Aug 13, 2024 | $18.30M | $19.26M | +5.22% | -$0.29 | -$0.26 | +10.34% | — | — |
| Q2 2024 May 8, 2024 | $17.30M | $18.12M | +4.76% | -$0.32 | -$0.32 | +0.00% | — | — |
| Q1 2024 Mar 5, 2024 | $17.46M | $18.01M | +3.16% | -$0.33 | -$0.23 | +30.30% | — | — |
| Q4 2023 Nov 6, 2023 | $15.79M | $16.43M | +4.03% | -$0.39 | -$0.28 | +28.21% | — | — |
| Q3 2023 Aug 8, 2023 | $12.62M | $16.51M | +30.82% | -$0.47 | -$0.36 | +23.40% | — | — |
| Q2 2023 May 4, 2023 | $12.17M | $14.47M | +18.92% | -$0.46 | -$0.41 | +10.87% | — | — |
| Q1 2023 Mar 2, 2023 | $12.17M | $12.79M | +5.09% | -$0.49 | -$0.45 | +8.16% | — | — |
| Q4 2022 Nov 8, 2022 | $9.90M | $11.16M | +12.70% | -$0.52 | -$0.48 | +7.69% | — | — |
| Q3 2022 Aug 11, 2022 | $11.08M | $10.20M | -7.94% | -$0.44 | -$0.52 | -18.18% | — | — |
| Q2 2022 May 12, 2022 | $10.64M | $11.37M | +6.86% | -$0.46 | -$0.47 | -2.17% | — | — |
| Q1 2022 Mar 10, 2022 | $11.00M | $11.00M | -0.03% | -$0.33 | -$0.44 | -33.33% | — | — |
| Q4 2021 Nov 10, 2021 | $8.96M | $10.34M | +15.38% | -$0.30 | -$0.34 | -13.33% | — | — |
| Q3 2021 Aug 12, 2021 | $11.30M | $12.63M | +11.77% | -$0.39 | -$0.36 | +7.69% | — | — |
| Q2 2021 Jun 3, 2021 | — | $11.22M | — | -$0.25 | -$21.21 | -8384.00% | — | — |